Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | POLB | P06746 | 3/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | TACR1 | P25103 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.55 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.55 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4210387 | 0.83 | GAA (0.81) | KMT2AMEN1L3MBTL1TSHRMAPK1 | |
| SCHEMBL14027531 | 0.81 | POLB (0.77) | KMT2AMEN1POLBL3MBTL1TP53 | |
| SCHEMBL4212345 | 0.78 | TSHR (0.72) | KMT2AMEN1POLBL3MBTL1TSHR | |
| SCHEMBL4211049 | 0.77 | TSHR (0.72) | KMT2AMEN1POLBL3MBTL1TSHR | |
| SCHEMBL6408638 | 0.77 | TP53 (0.74) | KMT2APOLBL3MBTL1TSHRMAPK1 | |
| SCHEMBL12858779 | 0.76 | KMT2A (0.76) | KMT2AMEN1POLBL3MBTL1TACR1 | |
| SCHEMBL4216766 | 0.75 | TSHR (0.60) | KMT2AMEN1POLBL3MBTL1TSHR | |
| SCHEMBL4207384 | 0.74 | TSHR (0.68) | POLBL3MBTL1TSHRMAPK1TACR1 | |
| SCHEMBL14732084 | 0.73 | L3MBTL1 (0.62) | POLBL3MBTL1TSHRMAPK1TP53 | |
| SCHEMBL4206084 | 0.73 | TSHR (0.73) | KMT2AMEN1POLBL3MBTL1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050288347-A1 | Certain triazole-based compounds, compositions, and uses thereof | AGRIUS GROUP, LLC. | 2005-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288347-A1 | Certain triazole-based compounds, compositions, and uses thereof | ABCG2, ATP5ME, DNTT | KMT2A 2263/4885MEN1 3562/4885POLB 854/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.